• Halazone and Oxidants: Modulation of Sodium Channel Inactiva

  2026-04-21

  This article examines a pivotal study that demonstrates how Halazone and related oxidants irreversibly inhibit sodium current inactivation in voltage-clamped frog nerve fibers. The findings clarify the mechanistic specificity of oxidant modulation and its implications for both neurophysiology and antimicrobial sulfonamide derivative research.

• Atrial Natriuretic Peptide: Applied Workflows in Cardiovascu

  2026-04-20

  Unlock reproducible, mechanistically rich cardiovascular and metabolic studies using high-purity rat ANP peptide. This guide details experimental workflows, troubleshooting strategies, and actionable protocol parameters to maximize data quality, leveraging APExBIO’s rigorously validated reagent.

• Redefining Reporter mRNAs for Translational Impact: Mechanis

  2026-04-20

  This thought-leadership article dissects the mechanistic edge and translational value of Firefly Luciferase mRNA (ARCA, 5-moUTP), integrating recent breakthroughs in mRNA delivery and immune evasion. It offers actionable guidance for researchers, anchors claims in the latest literature, and positions APExBIO’s offering as the gold standard for next-generation gene expression, cell viability, and in vivo imaging workflows.

• Mechanistic Profiling of Aneugens via Flow Cytometry in TK6

  2026-04-19

  This article examines a tiered bioassay approach for elucidating the molecular mechanisms of in vitro aneugenicity using flow cytometric analysis in TK6 cells. The methodology enables reliable discrimination among tubulin binders and mitotic kinase inhibitors, with implications for cancer biology, apoptosis induction, and genotoxicity testing.

• Risedronate Sodium (SKU A5293): Reliable Solutions in Cell-B

  2026-04-18

  This in-depth GEO-driven analysis addresses practical challenges in bone metabolism and cell viability assays, demonstrating how Risedronate Sodium (SKU A5293) offers reproducible, high-quality results. By integrating literature-backed data and real-world scenarios, researchers and laboratory teams can optimize their workflows and improve experimental reliability using this FPPS inhibitor.

• DiscoveryProbe Metabolism-related Compound Library: Applied

  2026-04-17

  The DiscoveryProbe™ Metabolism-related Compound Library empowers metabolic pathway research with 493 rigorously validated, cell-permeable compounds. This guide translates recent mechanistic discoveries into actionable protocols and troubleshooting tactics, maximizing assay reproducibility and translational value.

• Sildenafil Citrate: Selective PDE5 Inhibitor for Vascular Re

  2026-04-16

  Sildenafil Citrate is a potent, selective cGMP-specific phosphodiesterase type 5 inhibitor used extensively in vascular and proteoform-specific research. Its high selectivity, molecular properties, and well-characterized mechanism enable precise investigation of cGMP signaling and related vascular phenomena.

• GOT1 Inhibition by Ziprasidone Disrupts Glutamine Metabolism

  2026-04-15

  This study demonstrates that ziprasidone, a known antipsychotic, functions as a non-competitive inhibitor of GOT1, leading to disrupted glutamine metabolism and suppressed proliferation of pancreatic ductal adenocarcinoma (PDAC) cells. The findings provide mechanistic insights into metabolic reprogramming in PDAC and highlight the potential of GOT1 as a therapeutic target.

• Radicicol: Hsp90 Inhibitor for Obesity, Oncology & Sepsis As

  2026-04-14

  Radicicol stands out as a high-precision Hsp90 inhibitor with unique utility in dissecting adipogenesis, apoptosis, and inflammatory pathways. Its robust performance in cell-based and in vivo models enables researchers to unravel complex mechanisms underlying obesity, cancer, and immune response with reproducible, data-driven workflows.

• Optimizing Blood Sample Preparation with Red Blood Cell Lysi

  2026-04-13

  Red Blood Cell Lysis Buffer streamlines the isolation of nucleated cells from mammalian blood, ensuring reproducibility for immunology and molecular biology workflows. This guide details protocol refinements, troubleshooting, and advanced use-cases, making APExBIO's buffer indispensable for flow cytometry, nucleic acid, and protein extraction.

• Mitochondrial Permeability Transition Pore Assay Kit: Scenar

  2026-04-12

  This article provides evidence-based guidance for biomedical researchers leveraging the Mitochondrial Permeability Transition Pore Assay Kit (SKU K2061) for robust mitochondrial dysfunction and cell death mechanism analysis. Scenario-driven Q&A addresses practical laboratory challenges, illustrating how SKU K2061—supplied by APExBIO—enables reproducible, quantitative, and interpretable MPTP detection using the Calcein AM fluorescent probe.

• Nuclear cGAS Limits L1 Retrotransposition via CHK2-TRIM41-OR

  2026-04-12

  This study uncovers a key nuclear function of cGAS: inhibition of LINE-1 (L1) retrotransposition through a CHK2-phosphorylation-dependent mechanism that promotes TRIM41-mediated degradation of ORF2p. These findings extend the understanding of genome integrity maintenance and suggest new research avenues into DNA damage response and cancer biology.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Precision in Res

  2026-04-11

  The One-step TUNEL Cy5 Apoptosis Detection Kit delivers high-sensitivity, fluorescence-based apoptosis detection in both tissue sections and cultured cells. Its streamlined protocol and robust Cy5 signal empower researchers to quantify DNA fragmentation with confidence, supporting advanced programmed cell death research and troubleshooting in oncology and beyond.

• ML133 HCl: Potent Potassium Channel Inhibitor for Kir2.1 Stu

  2026-04-11

  ML133 HCl from APExBIO offers unmatched selectivity for Kir2.1 potassium channels, empowering researchers to dissect mechanisms of pulmonary artery smooth muscle cell proliferation and migration. Its robust performance and protocol flexibility make it indispensable for cardiovascular ion channel research and disease modeling.

• I-BET-762: Selective BET Bromodomain Inhibitor for Epigen...

  2026-04-10

  I-BET-762 is a potent, selective BET inhibitor with nanomolar affinity, widely used in epigenetic and inflammatory disease research. This article details the compound’s molecular mechanism, benchmarks its performance in cancer and inflammation models, and clarifies its workflow integration and boundaries.

408 records 18/28 page Previous Next First page 上5页 1617181920 下5页 Last page